1-methyl-3-isobutylxanthine has been researched along with sermorelin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichinose, M; Maeno, T; Sawada, M | 1 |
Alfonso, A; Botana, LM; Estévez, MD; Louzao, MC; Vieytes, MR | 1 |
2 other study(ies) available for 1-methyl-3-isobutylxanthine and sermorelin
Article | Year |
---|---|
Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Dose-Response Relationship, Drug; Female; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Phagocytosis; Sermorelin; Vasoactive Intestinal Peptide | 1994 |
Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Cell Division; Cholera Toxin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; GTP-Binding Proteins; Histamine Release; Humans; Mast Cells; Peritoneum; Pertussis Toxin; Pleura; Rats; Rats, Sprague-Dawley; Sermorelin; Tetradecanoylphorbol Acetate; Virulence Factors, Bordetella | 1995 |